Browse > Article
http://dx.doi.org/10.4062/biomolther.2008.16.2.106

The Harman and Norharman Reduced Dopamine Content and Induced Cytotoxicity in PC12 Cells  

Yang, Yoo-Jung (College of Pharmacy and Research Center for Bioresource and Health, Chungbuk National University)
Lim, Sung-Cil (College of Pharmacy and Research Center for Bioresource and Health, Chungbuk National University)
Lee, Myung-Koo (College of Pharmacy and Research Center for Bioresource and Health, Chungbuk National University)
Publication Information
Biomolecules & Therapeutics / v.16, no.2, 2008 , pp. 106-112 More about this Journal
Abstract
The effects of harman and norharman on dopamine content and L-DOPA-induced cytotoxicity were investigated in PC12 cells. Harman and norharman decreased the intracellular dopamine content for 24 h. The $IC_{50}$ values of harman and norharman were 20.4 ${\mu}M$ and 95.8 ${\mu}M$, respectively. Tyrosine hydroxylase (TH) activity and TH mRNA levels were also decreased by 20 ${\mu}M$ harman and 100 ${\mu}M$ norharman. Under the same conditions, the intracellular cyclic AMP levels were decreased by harman and norharman. In addition, harman and norharman at concentrations higher than 80 ${\mu}M$ and 150 ${\mu}M$ caused cytotoxicity at 24 h in PC12 cells. Non-cytotoxic ranges of 10-30 ${\mu}M$ harman and 50-150 ${\mu}M$ norharman inhibited L-DOPA (20-50 ${\mu}M$)-induced increases of dopamine content at 24 h. Harman at 20-150 ${\mu}M$ and norharman at 100-300 ${\mu}M$ also enhanced LDOPA (20-100 ${\mu}M$)-induced cytotoxicity at 24 h. These results suggest that harman and norharman decrease dopamine content by reducing TH activity and aggravate L-DOPA-induced cytotoxicity in PC12 cells.
Keywords
Harman; Norharman; Dopamine content; Tyrosine hydroxylase; PC12 cell;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Tischler, A.S., Perlman, R.L., Morse, G.M. and Sheard, B.E. (1983). Glucocorticoids increase catecholamine synthesis and storage in PC12 cells pheochromocytoma cell culture. J. Neurochem. 40, 364-370   DOI
2 Goldstein, M. (1995). Long- and short-term regulation of tyrosine hydroxylase. In: Bloom F.E., Kupfer D.J. (Eds.), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, 189-195
3 Matsubara, K., Collins, M.A., Akane, A., Ikebuchi, J., Neafsey, E.J., Kagawa, M. and Shiono, H. (1993). Potential bioactivated neurotoxicants, N-methylated $\beta$-carbolinium ions, are present in human brain. Brain Res. 610, 90-96   DOI   ScienceOn
4 Migheli, R., Godani, C., Bciola, L., Delodu, M.R., Serra, P.A., Zangani, D., Natale, G.D., Miele, E. and Desole, M.S. (1999). Enhancing effect of managanese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J. Neurochem. 73, 1155-1163   DOI
5 Pfau, W. and Skog, K. (2004). Exposure to $\beta$-carbolines norharman and harman. J. Chromatogr. B. 802, 115-126   DOI   ScienceOn
6 Sandstrom, P.A., Mannie, M.D. and Buttke, T.H. (1994). Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55, 221-226   DOI
7 Shin, J.S., Kim, E.I., Kai, M. and Lee, M.K. (2000). Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25, 363-368   DOI   ScienceOn
8 Breyer-Pfaff, U., Wiatr, G., Stevens, I., Gaertner, H.J., Mundle, G. and Mann, K. (1996). Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking. Life Sci. 58, 1425-1432   DOI   ScienceOn
9 Albores, R., Neafsey, E.J., Drucker, G., Fields, J.Z. and Collins, M.A. (1990). Mitochondrial respiratory inhibition by N-methylated ${\beta}$-carboline derivatives structurally resembling N-methyl- 4-phenylpyridine. Proc. Natl. Acad. Sci. USA. 87, 9368-9372   DOI   ScienceOn
10 Allen, J.R.F. and Holmstedt, B.R. (1980). The simple ${\beta}$-carboline alkaloids. Phytochem. 19, 1573-1582   DOI   ScienceOn
11 Ehringer, H. and Hornykiewicz, O. (1960). Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschr. 38, 1236-1239   DOI
12 Fields, J.Z., Albores, R., Neafsey, E.J. and Collins, M.A. (1992). Similar inhibition of mitochondrial respiration by 1-methyl-4- phenylpyridinium ($MPP^{+}$) and a unique N-methylated betacarboline analogue, 2,9-dimethyl-norharman (2,9-$Me_2NH$). Ann. N.Y. Acad. Sci. 648, 272-274   DOI
13 Gearhart, D.A., Collins, M.A., Lee, J.M. and Neafsey, E.J. (2000). Increased brain $\beta$-carboline-9N-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol. Dis. 7, 201-211   DOI   ScienceOn
14 Lee, M.K. and Kim, H.S. (1996). Inhibitory effects of protoberberine alkaloids from the root of Coptis japonica on catecholamine biosynthesis in PC12 cells. Planta Med. 62, 31-34   DOI   ScienceOn
15 Green, S., Buttrum, S., Molloy, H., Steventon, G., Sturman, S., Waring, R., Pall, H. and Williams, A. (1991). N-methylation of pyridines in Parkinson's disease. Lancet 338, 120-121
16 Kim, K.S., Park, D.H. and Joh, T.H. (1993). Parallel up-regulation of catecholamine biosynthesis enzymes by dexamethasone in PC12 cells. J. Neurochem. 60, 946-951   DOI
17 Lee, J.J., Kim, Y.M., Yin, S.Y., Park, H.D., Kang, M.H., Hong, J.T. and Lee, M.K. (2003). Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66, 1787-1795   DOI   ScienceOn
18 Lowry, O.H., Rosenbrough, N.L., Farr, A.L. and Randall, R.L. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
19 Marsden, C.D. (1994). Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 57, 672-681   DOI   ScienceOn
20 May, T., Rommelspacher, H. and Pawlik, M. (1991). [$^2H$]harman binding experiments: I. A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat. J. Neurochem. 56, 490-499   DOI
21 Cohen, G. (1983). The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence. J. Neural Transm. 19(Suppl.), 89-103   DOI
22 Deitrich, R. and Erwin, V. (1980). Biogenic amine-aldehyde condensation products: Tetrahydroisoquinolines and trytolines ($\beta$- carbolines). Annu. Rev. Pharmacol. Toxicol. 20, 55-80   DOI   ScienceOn
23 Nagatsu, T. (1997). Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29, 99-111   DOI   ScienceOn
24 Nagatsu, T., Oka, K. and Kato, K. (1979). Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr. 163, 247-252   DOI   ScienceOn
25 Neafsey, E.J., Drucker, G., Raikoff, K. and Collins, M.A. (1989). Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of Nmethy- 4-phenylpyridinium ion ($MPP^{+}$). Neurosci. Lett. 105, 344-349   DOI   ScienceOn
26 Kim, Y.M., Kim, M.N., Lee, J.J. and Lee, M.K. (2005). Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 386, 1-4   DOI   ScienceOn
27 Kuhn, W., Muller, T., Grobe, H., Dierks, T. and Rommelapacher, H. (1995). Plasma levels of the ${\beta}$-carbolines harman and norharman in Parkinson's disease. Acta Neurol. Scand. 92, 451- 454   DOI   ScienceOn
28 Shin, J.S., Lee, J.J., Kim, Y., Lee, C.K., Yun, Y.P. and Lee, M.K. (2001). Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull. 24, 103-105   DOI   ScienceOn
29 Kumer, S.C. and Vrana, K.E. (1996). Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443-462   DOI   ScienceOn
30 Shin, J.S., Kim, K.T. and Lee, M.K. (1998). Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett. 244, 161-164   DOI   ScienceOn
31 Shin, J.S., Yun-Choi, H.S., Kim, E.I. and Lee, M.K. (1999). Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65, 452-455   DOI   ScienceOn
32 Yin, S.Y., Kim, Y.M., Lee, J.J., Jin, C.M., Yang, Y.J., Ma, J.J., Kang, M.H., Kai, M. and Lee, M.K. (2004a). Enantio-selective inhibition of (1R,9S)- and (1S,9R)-${\beta}$-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol. 47, 1045-1052   DOI   ScienceOn
33 Yin, S.Y., Lee, J.J., Kim, Y.M., Jin, C.M., Yang, Y.J., Kang, M.H., Kai, M. and Lee, M.K. (2004b). Effects of (1R,9S)-$\beta$-hydrastine on L-DOPA-induced cytotoxicity in PC12 cells. Eur. J. Pharmacol. 488, 71-77   DOI   ScienceOn
34 McNaught, K.St.P., Carrupt, P.A., Altmore, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P. and Marsden, C.D. (1998). Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56, 921-933   DOI   ScienceOn